NeuPath Health Inc.
NPTH.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 12.87M | 13.80M | 12.97M | 12.35M | 11.99M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.87M | 13.80M | 12.97M | 12.35M | 11.99M |
| Cost of Revenue | 10.51M | 11.03M | 10.57M | 9.98M | 9.80M |
| Gross Profit | 2.36M | 2.77M | 2.40M | 2.38M | 2.19M |
| SG&A Expenses | 1.83M | 1.82M | 1.79M | 1.82M | 1.72M |
| Depreciation & Amortization | 421.60K | 404.10K | 430.90K | 542.50K | 467.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.76M | 13.26M | 12.79M | 12.34M | 11.99M |
| Operating Income | 107.00K | 539.30K | 175.00K | 14.00K | 4.50K |
| Income Before Tax | -198.70K | 312.80K | -212.90K | -280.00K | 366.10K |
| Income Tax Expenses | 38.10K | 48.20K | 42.30K | -9.60K | 100.60K |
| Earnings from Continuing Operations | -236.80K | 264.60K | -255.20K | -270.50K | 265.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -57.20K | -48.20K | -25.20K | -700.00 | 15.70K |
| Net Income | -294.00K | 216.30K | -280.40K | -271.20K | 281.10K |
| EBIT | 107.00K | 539.30K | 175.00K | 14.00K | 4.50K |
| EBITDA | 528.60K | 943.50K | 606.00K | 230.60K | 471.90K |
| EPS Basic | -0.01 | 0.00 | -0.01 | 0.00 | 0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | 0.00 | -0.01 | 0.00 | 0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 56.39M | 56.31M | 56.29M | 56.29M | 56.27M |
| Average Diluted Shares Outstanding | 56.60M | 56.67M | 56.53M | 56.29M | 56.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
